Pharmacological treatment of attention-deficit hyperactivity disorder comorbid with an anxiety disorder

2019 ◽  
Vol 34 (2) ◽  
pp. 57-64 ◽  
Author(s):  
Camila B. Villas-Boas ◽  
Danielly Chierrito ◽  
Fernando Fernandez-Llimos ◽  
Fernanda S. Tonin ◽  
Andréia C.C. Sanches
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Anxiety Disorder ◽  
Attention Deficit ◽  
Pharmacological Treatment ◽  
Hyperactivity Disorder

scholarly journals Clinical effects of nonpharmacological treatment of ADHD

2021 ◽  
Author(s):  
Matheus Almeida Ribeiro da Cunha ◽  
João Gustavo dos Anjos Morais Oliveira ◽  
Gabriela Sarno Brandão ◽  
Ana Flávia Paiva Bandeira Assis ◽  
Leonardo Mattos Santos ◽  
...  
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Attention Deficit ◽  
Pharmacological Treatment ◽  
Methodological Quality ◽  
Pharmacological Therapy ◽  
Pharmacological Intervention ◽  
Clinical Effects ◽  
Nonpharmacological Treatment ◽  
Hyperactivity Disorder ◽  
School Of Medicine

Background: Though pharmacotherapy of Attention Deficit Hyperactivity Disorder (ADHD) is widespread, some patients suffer with side effects or do not improve with it. Objectives: Evaluate clinical outcomes of non-pharmacological therapy on ADHD. Design and Setting: This is a literature review, produced in Bahiana School of Medicine and Public Health. Methods: Articles published between 2011 and 2021 were taken from PubMed, using the following search: (“Non-pharmacological treatment” OR “Non- pharmacological therapy” OR “Non-pharmacological intervention” OR “Non-drug treatment” OR “Non-drug therapy” OR “Adjuvant treatment” OR “Adjuvant therapy”) AND (“ADHD” OR “Attention Deficit-Hyperactivity Disorder”). Studies that did not match this review’s objectives were excluded. Results: 20 of the 57 articles found, were selected. Reviews that approach treatment in general indicate non-pharmacological therapy specially when there are obstacles to use of drugs, but highlight the lack of studies with methodological quality in this field. Clinical studies indicate reduction of symptoms through neurofeedback, transcranial magnetic stimulation, and aerobic exercises. One of the interventions with the most articles was nutritional supplementation, though most of them did not find significant improvement. Conclusions: Non-pharmacological treatment of ADHD is a relevant alternative, especially when there is no response to medication, but studies with better methodological quality are necessary.

scholarly journals Pharmacological Treatment of Attention Deficit Hyperactivity Disorder in Children and Adolescents: Clinical Strategies

2012 ◽  
Vol 5 ◽  
pp. JCNSD.S6691 ◽  
Author(s):  
Anna C. Shier ◽  
Thomas Reichenbacher ◽  
Harinder S. Ghuman ◽  
Jaswinder K. Ghuman
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Children And Adolescents ◽  
Attention Deficit ◽  
Pharmacological Treatment ◽  
First Line ◽  
Pharmacological Agents ◽  
Ample Evidence ◽  
Hyperactivity Disorder ◽  
Impaired Quality

Attention deficit hyperactivity disorder (ADHD) is a common neurobehavioral disorder of childhood that can result in significant functional impairment, and if not adequately treated can lead to impaired quality of life. Pharmacotherapy is considered the first-line treatment for ADHD in children and adolescents. We review both recent literature and seminal studies regarding the pharmacological treatment of ADHD in children and adolescents. There is ample evidence for the efficacy and safety of both stimulants and non-stimulants in the treatment of ADHD. We review important aspects of evaluation and assessment and discuss first-line pharmacological treatments and as well as when to consider using alternative pharmacological agents. Treatment approaches to manage frequently seen comorbid disorders with ADHD are also covered.

Treatment of Comorbid Adult Attention-deficit/Hyperactivity Disorder and Generalized Anxiety Disorder

2018 ◽  
Vol 24 (4) ◽  
pp. 292-298 ◽  
Author(s):  
FRANCESCO OLIVA ◽  
CLAUDIO CAREZANA ◽  
GABRIELE NIBBIO ◽  
STEFANO BRAMANTE ◽  
ALBERTO PORTIGLIATTI POMERI ◽  
...  
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Anxiety Disorder ◽  
Generalized Anxiety Disorder ◽  
Attention Deficit ◽  
Generalized Anxiety ◽  
Hyperactivity Disorder

scholarly journals Anxiety disorders in an attention-deficit/hyperactivity disorder clinical sample

2005 ◽  
Vol 63 (2b) ◽  
pp. 407-409 ◽  
Author(s):  
Isabella Souza ◽  
Maria Antônia Pinheiro ◽  
Paulo Mattos
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Anxiety Disorder ◽  
Anxiety Disorders ◽  
Children And Adolescents ◽  
Attention Deficit ◽  
Clinical Sample ◽  
Structured Interview ◽  
Separation Anxiety Disorder ◽  
Clinical Samples ◽  
Hyperactivity Disorder

OBJECTIVE: To evaluate the prevalence of anxiety disorders in a clinical referred sample of children and adolescents with attention deficit/hyperactivity disorder (ADHD). METHOD: 78 children and adolescents with ADHD according to DSM-IV criteria were investigated with a semi-structured interview (P-CHIPS), complemented by clinical interviews with the children or adolescents and their parents. Their IQ was calculated with neuropsychological testing. RESULTS: A high prevalence of anxiety disorders (23.05%) was found in the sample. Generalized anxiety disorder was the most prevalent disorder (12,8%), followed by social phobia (3,84%) and separation anxiety disorder (3,8%). Two children showed more than one anxiety disorder. CONCLUSION: Children and adolescents with ADHD seem to be more prone to have comorbid anxiety disorders, at least in clinical samples referred to specialized units.

scholarly journals Extended-release methylphenidate monotherapy in patients with comorbid social anxiety disorder and adult attention-deficit/hyperactivity disorder: retrospective case series

2017 ◽  
Vol 7 (11) ◽  
pp. 241-247 ◽  
Author(s):  
Ahmet Koyuncu ◽  
Fahri Çelebi ◽  
Erhan Ertekin ◽  
Burcu Ece Kök ◽  
Raşit Tükel
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Anxiety Disorder ◽  
Social Anxiety ◽  
Social Anxiety Disorder ◽  
Attention Deficit ◽  
Adult Adhd ◽  
Extended Release ◽  
Case Series ◽  
Hyperactivity Disorder ◽  
The Relationship

Background: The relationship between social anxiety disorder (SAD) and attention-deficit/hyperactivity disorder (ADHD) is a subject which has recently become a topic of interest for research. Methods: In this study, 20 patients with comorbid SAD and adult ADHD who were treated with extended-release methylphenidate monotherapy were evaluated retrospectively. Results: Clinical response for both ADHD and SAD symptoms was observed in 17 of 20 patients. Overall, one patient did not respond to treatment and two patients dropped out of treatment at the beginning due to adverse effects. Conclusion: Extended-release methylphenidate improved both SAD and ADHD symptoms and was generally well tolerated. Further studies are required to investigate the relationship between SAD and ADHD.

Sign in / Sign up

Export Citation Format

Share Document